Print

Shire Pharmaceuticals (SHPG) Hunts More Deals Amid Reawakening Interest in Stem Cell R&D  
10/29/2012 7:06:19 AM

Shire Pharmaceuticals | Jobs at Shire Pharmaceuticals

As the Stem Cell Meeting on the Mesa convenes its second annual investor and partnering forum in San Diego this morning, Dean Tozer says the last 18 to 24 months have seen a rejuvenation of interest in the commercial prospects for biomedical products arising from stem cell research and development.

//-->